Summarises the ADTC position on generic prescribing
Generic Prescribing: Guidance for Prescribers in NHSGGC
Posted: Friday, March 26, 2021
Category - Medicines Update
Medicines Update -2021
For all healthcare professionals across NHSGGC both in primary care and the acute sector.
- Subscribe to our blog via email: medicines.update@ggc.scot.nhs.uk
- Follow us on Twitter
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact medicines.update@ggc.scot.nhs.uk.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC resposnsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.
06/09/2023 announcement
Accessing GGC Clinical Guidelines via Medicines Update blogs and the Adult Therapeutics Handbook
GGC Clinical Guidelines have migrated to the Right Decisions for Health and Care platform. As a result of the migration, direct links to GGC guidelines within Medicines Update blogs (and the Adult Therapeutics Handbook, GGC Medicines App) currently go to the homepage and not individual guidelines. This change was out with our control.
Please note, there is a message on the homepage highlighting intermittent issues with the search function, therefore, if you cannot find a guideline via the search box, select the relevant category from the homepage or if the guideline still can't be found, contact clinical.guidelines@ggc.scot.nhs.uk.
An update will be provided in due course.
MHRA Drug Safety Update for February 2021
Posted: Friday, March 26, 2021
Category - Medicines Update
MHRA Drug Safety Update for February 2021
How can I contribute to Medicines Update?
Posted: Friday, March 26, 2021
Category - Medicines Update
If you are a healthcare professional in NHSGGC and you would like to contribute to Medicines Update, we would love to hear from you.
Topical Emollients and Fire Hazard Risk
Posted: Friday, March 26, 2021
Category - Medicines Update
Patients who are prescribed paraffin containing emollients should be advised by clinicians of fire hazard and how to minimise risk.
Guideline News February 2021
Posted: Friday, March 5, 2021
Category - Medicines Update
Guideline News February 2021
Key Medicine Shortages – February 2021
Posted: Tuesday, March 2, 2021
Category - Medicines Update
Key Medicine Shortages for February 2021
Linezolid Adult Protocol Update
Posted: Tuesday, March 2, 2021
Category - Medicines Update
Key Messages
NHSGGC adult guidelines for linezolid have been updated and now include:
- An outpatient and discharge supply checklist to be completed by the prescriber
- Instructions of when and how to refer a patient to the NHSGGC Outpatient Antimicrobial Therapy (OPAT) service for follow-up monitoring
Management of Type 2 Diabetes – What’s New?
Posted: Friday, February 26, 2021
Category - Medicines Update
Management of Type 2 Diabetes – What’s New?
Summary
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists benefits in cardiovascular and renal outcomes
- Canagliflozin and Diabetic Kidney disease (DKD) licence extension
- Semaglutide, the first oral GLP-1 receptor agonist
Guidance At End Of Life (GAEL) - Updated
Posted: Friday, February 26, 2021
Category - Medicines Update
The updated guidance includes:
- The 4 main principles drawn from Caring for people in the last days and hours of life – NHS Scotland 2014
- Key actions when someone is dying and at the time of and after death
- Clear guidance on Anticipatory/Just In Case medication and advice on when to seek support and advice
- Electronic links throughout that can be accessed to provide additional information
Apremilast - New prescribing and supply arrangements
Posted: Friday, February 26, 2021
Category - Medicines Update
From February 2021, the maintenance dose of apremilast (one 30mg tablet twice daily) will be prescribed by the patient’s GP (one pack of 56 tablets per prescription). Specialist dermatology and rheumatology services will continue to prescribe the initial titration pack for new patients, and as before this will be dispensed in community pharmacies.